おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
NovoCodex
company
About
NovoCodex has been engaged in the business of genetic engineering, and cell culture, among others.
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥400M
- Industries
- Clinical Trials,Health Care,Product Research
- Founded date
- Jan 1, 2015
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥400M
NovoCodex has raised a total of
¥400M
in funding over 2 rounds. Their latest funding was raised on
Mar 19, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 19, 2021 | Series A | ¥400M | 1 |
Lilly Asia Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
NovoCodex is funded by 1 investors.
Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lilly Asia Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
